Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monique van der Kooij"'
Autor:
Eystein S Husebye, Frederik Castinetti, Sherwin Criseno, Giuseppe Curigliano, Brigitte Decallonne, Maria Fleseriu, Claire E Higham, Isabella Lupi, Stavroula A Paschou, Miklos Toth, Monique van der Kooij, Olaf M Dekkers
Publikováno v:
European Journal of Endocrinology (EJE)
G1-G21
European Journal of Endocrinology
European Journal of Endocrinology, 2022, 187 (6), pp.G1-G21. ⟨10.1530/EJE-22-0689⟩
G1-G21
European Journal of Endocrinology
European Journal of Endocrinology, 2022, 187 (6), pp.G1-G21. ⟨10.1530/EJE-22-0689⟩
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment but are associated with significant autoimmune endocrinopathies that pose both diagnostic and treatment challenges. The aim of this guideline is to provide clinicians with the be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445c006e3c368fd6e3149aeb486321eb
https://lirias.kuleuven.be/handle/20.500.12942/704726
https://lirias.kuleuven.be/handle/20.500.12942/704726
Autor:
Daan Jan Willem Rauwerdink, Remco van Doorn, Jos van der Hage, Alfonsus J. M. Van den Eertwegh, John B. A. G. Haanen, Maureen Aarts, Franchette Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan Willem B. De Groot, Geke A. P. Hospers, Melissa de Meza, Djura Piersma, Rozemarijn S. Van Rijn, Marion Stevense, Astrid Van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Karijn Suijkerbuijk, Monique van der Kooij, Ellen Kapiteijn
Publikováno v:
Cancers, 14(22):5694. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers; Volume 14; Issue 22; Pages: 5694
Cancers, 14(22):5694. MDPI AG
Cancers, 14(22). MDPI
Rauwerdink, D J W, van Doorn, R, van der Hage, J, van den Eertwegh, A J M, Haanen, J B A G, Aarts, M, Berkmortel, F, Blank, C U, Boers-Sonderen, M J, de Groot, J W B, Hospers, G A P, de Meza, M, Piersma, D, van Rijn, R S, Stevense, M, van der Veldt, A, Vreugdenhil, G, Wouters, M W J M, Suijkerbuijk, K, van der Kooij, M & Kapiteijn, E 2022, ' Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma : A Nation-Wide Study of the Dutch Melanoma Treatment Registry ', Cancers, vol. 14, no. 22, 5694 . https://doi.org/10.3390/cancers14225694
Cancers, 14, 22
Cancers, 14
Cancers; Volume 14; Issue 22; Pages: 5694
Cancers, 14(22):5694. MDPI AG
Cancers, 14(22). MDPI
Rauwerdink, D J W, van Doorn, R, van der Hage, J, van den Eertwegh, A J M, Haanen, J B A G, Aarts, M, Berkmortel, F, Blank, C U, Boers-Sonderen, M J, de Groot, J W B, Hospers, G A P, de Meza, M, Piersma, D, van Rijn, R S, Stevense, M, van der Veldt, A, Vreugdenhil, G, Wouters, M W J M, Suijkerbuijk, K, van der Kooij, M & Kapiteijn, E 2022, ' Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma : A Nation-Wide Study of the Dutch Melanoma Treatment Registry ', Cancers, vol. 14, no. 22, 5694 . https://doi.org/10.3390/cancers14225694
Cancers, 14, 22
Cancers, 14
Simple Summary Nodular melanoma is associated with a higher locoregional recurrence rate and worse overall survival outcomes. Whether this histologic subtype affects the efficacy of immunotherapy or targeted therapy is unclear. The aim of our multi-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2a366d12cc9bed6119db95220e29b3
https://cris.maastrichtuniversity.nl/en/publications/3921a6bb-e730-40d2-997e-c0963612d290
https://cris.maastrichtuniversity.nl/en/publications/3921a6bb-e730-40d2-997e-c0963612d290